Childress Capital Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.54M | Buy |
8,310
+1,667
| +25% | +$309K | 0.39% | 43 |
|
|
2025
Q1 | $1.39M | Buy |
6,643
+89
| +1% | +$18.6K | 0.4% | 46 |
|
|
2024
Q4 | $1.16M | Sell |
6,554
-69
| -1% | -$12.3K | 0.32% | 52 |
|
|
2024
Q3 | $1.31M | Buy |
6,623
+121
| +2% | +$23.9K | 0.35% | 49 |
|
|
2024
Q2 | $1.12M | Buy |
6,502
+138
| +2% | +$23.7K | 0.31% | 54 |
|
|
2024
Q1 | $1.16M | Sell |
6,364
-466
| -7% | -$84.9K | 0.34% | 52 |
|
|
2023
Q4 | $1.06M | Buy |
6,830
+251
| +4% | +$38.9K | 0.32% | 52 |
|
|
2023
Q3 | $983K | Buy |
+6,579
| New | +$983K | 0.32% | 55 |
|
|
2023
Q2 | – | Sell |
-2,123
| Closed | -$338K | – | 75 |
|
|
2023
Q1 | $338K | Sell |
2,123
-5,024
| -70% | -$801K | 0.15% | 61 |
|
|
2022
Q4 | $1.16M | Buy |
7,147
+531
| +8% | +$85.8K | 0.38% | 48 |
|
|
2022
Q3 | $899K | Sell |
6,616
-210
| -3% | -$28.5K | 0.35% | 53 |
|
|
2022
Q2 | $1.05M | Buy |
6,826
+293
| +4% | +$44.9K | 0.41% | 49 |
|
|
2022
Q1 | $1.06M | Buy |
6,533
+125
| +2% | +$20.3K | 0.37% | 50 |
|
|
2021
Q4 | $868K | Sell |
6,408
-1,655
| -21% | -$224K | 0.36% | 54 |
|
|
2021
Q3 | $869K | Buy |
8,063
+3,913
| +94% | +$422K | 0.35% | 58 |
|
|
2021
Q2 | $467K | Sell |
4,150
-3,711
| -47% | -$418K | 0.21% | 82 |
|
|
2021
Q1 | $850K | Buy |
7,861
+2,525
| +47% | +$273K | 0.39% | 49 |
|
|
2020
Q4 | $574K | Buy |
+5,336
| New | +$574K | 0.34% | 37 |
|